The biotech sector remains one of the most dynamic areas of the market, driven by clinical breakthroughs, regulatory decisions, and…
Read More »Shuttle Pharmaceuticals
Shuttle Pharmaceuticals (NASDAQ: SHPH) has locked in a $4.25 million private placement with an accredited investor, bolstering its war chest…
Read More »
Shuttle Pharmaceuticals (NASDAQ: SHPH) is doubling down on its mission to revolutionize cancer treatment with radiation therapy. In just a…
Read More »
Shuttle Pharmaceuticals (NASDAQ: SHPH) took center stage at the Planet MicroCap Showcase: VEGAS 2025 on April 23, offering investors and…
Read More »
Biotech can be brutal, but when a tiny stock with a tight float and a powerful narrative starts to run,…
Read More »
Shuttle Pharmaceuticals (NASDAQ: SHPH) is advancing its mission to revolutionize prostate cancer treatment. On April 10, 2025, the company announced…
Read More »
As President Trump’s sweeping tariffs and immigration policies continue to weigh on financial markets, many investors have taken a step…
Read More »
Shuttle Pharmaceuticals (NASDAQ: SHPH), a specialty pharmaceutical company dedicated to enhancing radiation therapy outcomes for cancer patients, reported the closing…
Read More »
Shuttle Pharmaceuticals (NASDAQ: SHPH), a specialty pharmaceutical company dedicated to enhancing radiation therapy outcomes for cancer patients, has taken two…
Read More »
Shuttle Pharmaceuticals (NASDAQ: SHPH) has filed its Annual Report on Form 10-K for the fiscal year ending December 31, 2024,…
Read More »